Lab Information
Sasha Bernatsky (MD/PhD)
Senior ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Pharmacoepidemiology • systemic lupus • rheumatic disease • drug safety and effectiveness • air pollutionResearch Interests
My research focuses mainly on outcomes in rheumatic diseases, pharmacoepidemiology, and air pollution’s effects on health.Team Members
| Name | Position |
|---|
Latest Publications
- Birck, M. G., Lukusa, L., Choquette, D., Boire, G., Maksymowych, W. P., Singh, H., Afif, W. & Bernatsky, S. (2024). Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data. BMC rheumatology, vol. 8, p. 47.
- Hitchon, C. A., Bowdish, D. M. E., Boire, G., Fortin, P. R., Flamand, L., Chandran, V., Dayam, R. M., Gingras, A.-C., Card, C. M., Colmegna, I., Larché, M. J., Kaplan, G. G., Lukusa, L., Lee, J. L. F., Bernatsky, S. & (2024). Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study. Vaccines, vol. 12.
- Tsyruk, O., Kaplan, G. G., Fortin, P. R., Hitchon, C. A., Chandran, V., Larché, M. J., Avina-Zubieta, A., Boire, G., Colmegna, I., Lacaille, D., Lalonde, N., Proulx, L., Richards, D. P., Boivin, N., DeBow, C., Kovalova-Wood, L., Paleczny, D., Wilhelm, L., Lukusa, L., Pereira, D., Lee, J. L., Bernatsky, S. & (2024). How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study. Vaccines, vol. 12.
- Bernatsky, S. (2024). Dr. Bernatsky replies. The Journal of rheumatology, vol. 51, p. 1150.
- Mendel, A., Behlouli, H., Vinet, É., Curtis, J. R. & Bernatsky, S. (2024). Trimethoprim sulfamethoxazole prophylaxis and serious infections in granulomatosis with polyangiitis treated with rituximab. Rheumatology (Oxford, England).
- Zhao, N., Smargiassi, A., Chen, H., Widdifield, J. & Bernatsky, S. (2024). Fine particulate matter components and risk of rheumatoid arthritis: A large general Canadian open cohort study. Arthritis care & research.
- Habib, R., Dayam, R. M., Hitchon, C., Chandran, V., Fortin, P. R., Boire, G., Bowdish, D. M. E., Gingras, A.-C., Flamand, L., Larché, M. J., Colmegna, I., Lukusa, L., Lee, J. L. F., Pereira, D., Bernstein, C. N., Lalonde, N., Turnbull, E., Bernatsky, S. & SUCCEED investigative team (2024). Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort Study. ACR open rheumatology, vol. 6, p. 581-586.
- Zhao, K., Oualkacha, K., Zeng, Y., Shen, C., Klein, K., Lakhal-Chaieb, L., Labbe, A., Pastinen, T., Hudson, M., Colmegna, I., Bernatsky, S. & Greenwood, C. M. T. (2024). Addressing dispersion in mis-measured multivariate binomial outcomes: A novel statistical approach for detecting differentially methylated regions in bisulfite sequencing data. Statistics in medicine, vol. 43, p. 3899-3920.
- Lee, J. J. Y., Bernatsky, S., Benchimol, E. I., Kuenzig, M. E., Kwong, J. C., Li, Q. & Widdifield, J. (2024). COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease - a population-based self-controlled case series analysis. BMC gastroenterology, vol. 24, p. 189.
- Barber, M. R. W., Ugarte-Gil, M. F., Hanly, J. G., Urowitz, M. B., St-Pierre, Y., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M., Ginzler, E. M., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., van Vollenhoven, R. F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S. S., Inanc, M., Kalunian, K. C., Jacobsen, S., Peschken, C. A., Kamen, D. L., Askanase, A., Pons-Estel, B. A., Cardwell, F. S., Alarcón, G. S. & Clarke, A. E. (2024). Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the rheumatic diseases, vol. 83, p. 1295-1303.
See also
